Description
CV70 is a 1,8-Diaza-anthracene-tetrone compound that exhibits anticancer activity in vitro, inhibiting the activation of JNK and ERK5.
CV70 is a 1,8-Diaza-anthracene-tetrone compound that exhibits anticancer activity in vitro, inhibiting the activation of JNK and ERK5.
Purity | ≥70% |
---|---|
Formula | C16H14N2O4 |
Formula Wt. | 298.29 |
Appearance | Red Powder |
Store Temp | -20°C |
---|---|
Ship Temp | Ambient |
MSDS | |
---|---|
Info Sheet | |
Brochures |
Pipaón C, Gutierrez P, Montero JC, et al. Mitogen-activated protein kinase routes as targets in the action of diaza-anthracene compounds with a potent growth-inhibitory effect on cancer cells. Mol Cancer Ther. 2002 Aug;1(10):811-9. PMID: 12492114.
JAK2 inhibitor.
Endogenous purine derivative of xanthine.
Found in Piper longum; TxA2 antagonist, ubiquit...
NSAID; COX-2 inhibitor.
MET and GSK-3α/β inhibitor.
Synthetic peptide, vasopressin analog; AVPR1 ag...
H+/K+ ATPase and Scpc phosphatase inhibitor.
FIASMA, 5-HT3 and σ1 agonist, SERT inhibitor.<...
p110α PI3K inhibitor.
ATP competitive CDK inhibitor.
Endogenous amino sugar precursor required for p...
Induces ER degradation.
H1 histamine and LT antagonist, PDE inhibitor.<...
Endogenous purine nucleotide base, required for...
mTOR inhibitor.
Peptide, used to deliver conjugated drugs to ce...
Tryptamine; 5-HT1B/1D agonist, TRPV1 antagonist...
GHB agonist, D2/3 antagonist.
Organosulfur found in Allium; analog of alliin....